Physician profile
Deviprasad Venugopal
NPI 1770767527
$6,937.03
in general payments reported to CMS, 2019-2025
29 companies · $1,071 in 2025
The $1,071 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $55.39 · 2021: $384 · 2022: $3,059 · 2023: $1,858 · 2024: $249 · 2025: $1,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,028 · Travel and Lodging: $1,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,028.00 |
| Travel and Lodging | $1,150.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,480.19 | 2022-2025 | Pulseselect, Micra, Aurora Ev-Icd Mri Surescan |
| Medical Device Business Services, INC. | $1,166.15 | 2022 | |
| Biosense Webster, INC. | $583.74 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Abbott Laboratories | $385.87 | 2021-2025 | Ensite, Amplatzer Amulet |
| Janssen Pharmaceuticals, INC | $182.29 | 2019-2023 | Xarelto |
| Altathera Pharmaceuticals LLC | $142.19 | 2023 | Sotalol Hydrochloride |
| Alexion Pharmaceuticals, INC. | $124.62 | 2021 | |
| Amgen INC. | $83.51 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $83.33 | 2022 | |
| Chiesi USA, INC. | $74.86 | 2021-2023 | Kengreal |
| Astrazeneca Pharmaceuticals LP | $69.61 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.62 | 2021-2024 | Lifevest |
| Pfizer INC. | $55.31 | 2019-2023 | |
| Shockwave Medical, INC | $48.30 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $47.83 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $46.82 | 2021-2025 | General - Tachy |
| Philips North America LLC | $42.54 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $38.79 | 2022-2023 | Onpattro |
| Ethicon US, LLC | $29.24 | 2024 | Surgicel Nu-Knit |
| Merck Sharp & Dohme LLC | $28.42 | 2022-2023 | Verquvo |
| Abiomed | $25.20 | 2022 | |
| Pharming Healthcare, INC. | $22.70 | 2023 | Ruconest |
| Atricure, INC. | $21.88 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $17.76 | 2023 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $17.55 | 2023 | Uptravi, Opsumit |
| Baxter Healthcare | $17.01 | 2023 | Hillrom - Life 2000 Ventilation System |
| Terumo Medical Corporation | $13.77 | 2021 | |
| Cvrx, INC. | $13.06 | 2023 | Barostim Neo System |
| Novo Nordisk INC | $12.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deviprasad Venugopal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.